Evidence map›Paper›PMID 35116377›Full record

ArticleTranslational cancer research2021

Xiang Wei, Liang Chen, Aiming Yang, Zhaoyu Lv, Meng Xiong, Chengxiang Shan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. In silico approach andContemporary oncology (Poznan, Poland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Current issues in molecular biology · 2024
    Article
  9. Review
  10. β-Adrenoceptors in Cancer: Old Players and New Perspectives.Handbook of experimental pharmacology · 2024
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiang Wei *Department of Anesthesiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Liang Chen *Department of Anesthesiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Aiming Yang *Department of Anesthesiology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zhaoyu LvDepartment of Anesthesiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Meng XiongDepartment of Anesthesiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Chengxiang ShanThird Division of Department of General Surgery of Second Affiliated Hospital of Naval Military Medical University, Shanghai, China.
Second Military Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer (BRCA) is the leading cause of cancer death among females. Studies suggested that β-adrenoceptors involved in tumor progression by regulating immune system. However, how

methodsExpressions of

results

conclusionsIn conclusion,

Indexed as

ADRB2bioinformatic analysisBreast cancer (BRCA)immune infiltrationtumor immune microenvironment

Identifiers

PMID35116377
PMCPMC8798932
OpenAlexW4205363406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.